Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Lanatoside C - 95%, high purity , Sodium/potassium-transporting ATPase inhibitor, CAS No.17575-22-3, Sodium/potassium-transporting ATPase inhibitor

  • ≥95%
Item Number
L121090
Grouped product items
SKUSizeAvailabilityPrice Qty
L121090-25mg
25mg
In stock
$35.90
L121090-100mg
100mg
In stock
$110.90
Add to Wish List Compare
Bulk Order  SDS  DATASHEET
View related series
Autophagy

Basic Description

SynonymsAllocor | NSC-7533 | Digilanogen C | Digilanide C | Lanocide-C | 5RR3JFZ771 | Cedilanid | NSC-119991 | Lanatosid C | DTXSID7023198 | Lanatigen C | Cetosanol | lanatoside C | Isolanid | Isolanide | Celanid | Desacetyllanatoside | Ceglunate | Celadigal
Specifications & Purity≥95%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
Action TypeINHIBITOR
Mechanism of actionSodium/potassium-transporting ATPase inhibitor
Product Description

Lanatoside C is a cardiac glycoside, can be used in the treatment of congestive heart failure and cardiac arrhythmia.Lanatoside C has an IC50 of 0.19 μM for dengue virus infection in HuH-7 cells. Lanatoside C can effectively inhibit all four serotypes of dengue virus, flavivirus Kunjin, alphavirus Chikungunya, Sindbis virus and the human enterovirus 71

Product Properties

ALogP0.2

Associated Targets(Human)

PAX8 Tchem Paired box protein Pax-8 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THRB Tclin Thyroid hormone receptor beta-1 (7926 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-5 (45555 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

dengue virus type 4 (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dengue virus type 1 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dengue virus type 2 (2400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
dengue virus type 3 (207 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate
INCHI InChI=1S/C49H76O20/c1-21-43(67-38-17-32(53)44(22(2)62-38)68-39-18-33(64-24(4)51)45(23(3)63-39)69-46-42(58)41(57)40(56)34(19-50)66-46)31(52)16-37(61-21)65-27-9-11-47(5)26(14-27)7-8-29-30(47)15-35(54)48(6)28(10-12-49(29,48)59)25-13-36(55)60-20-25/h13,21-23,26-35,37-46,50,52-54,56-59H,7-12,14-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29-,30+,31+,32+,33+,34-,35-,37+,38+,39+,40-,41+,42-,43-,44-,45-,46+,47+,48+,49+/m1/s1
InChi Key JAYAGJDXJIDEKI-PTGWOZRBSA-N
Canonical SMILES C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@H]7[C@@H]6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5
Isomeric SMILES C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3C[C@H]([C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)O)C)O)O[C@H]7C[C@@H]([C@@H]([C@H](O7)C)O[C@H]8C[C@@H]([C@@H]([C@H](O8)C)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)OC(=O)C)O
WGK Germany 3
PubChem CID 656630
Molecular Weight 985.12

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
G2429400Certificate of AnalysisJul 05, 2024 L121090
G2429401Certificate of AnalysisJul 05, 2024 L121090
B23211018Certificate of AnalysisJan 04, 2023 L121090
B23211110Certificate of AnalysisJan 04, 2023 L121090

Safety and Hazards(GHS)

Pictogram(s) GHS06
Signal Danger
Hazard Statements

H301:Toxic if swallowed

H311:Toxic in contact with skin

H331:Toxic if inhaled

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P301+P310:IF SWALLOWED: Immediately call a POISON CENTER/doctor/...

P311:Call a POISON CENTER or doctor/...

WGK Germany 3

Related Documents

 SDS

 Specification Sheet

Alternative Products

  1. Lanatoside C - 10mM in DMSO, used for , CAS No. 17575-22-3, by Aladdin Scientific
    Lanatoside C
    • 10mM in DMSO

    Starting at $241.90

FAQs and Articles

FAQ
JAK-STAT Cell Signaling Pathway
Categories: Technical articles
Tags:
treat tumors leukemia JAK family kinases

References

1. P Sandouk,J M Scherrmann,M Galliot,R Bourdon.  (1986-07-05)  [Guidelines for prescription of the assay of digitalis glycosides by immunologic methods]..  Presse medicale (Paris, France : 1983),  15  ((27)): (1273-1275).  [PMID:2945182]
2. P H Jiao,L Jin,Q Fang,L Xu,M Y Xie.  (1986-06-01)  [Clinical application of the determination of serum digoxin concentration]..  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,  8  ((3)): (214-217).  [PMID:2946462]
3. T F Huang,M L Wu.  (1987-11-01)  Electrophysiological study on hypertrophied and ischemic myocardial of rats..  Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,  86  ((11)): (1156-1160).  [PMID:2965213]
4. T Bogdanik,M Warmus,W Geraga,J Zambrzycki.  (1986-08-01)  [Practical use of computer technics and nomograms in controlling treatment using digitalis preparations]..  Polskie Archiwum Medycyny Wewnetrznej,  76  ((2)): (80-88).  [PMID:3575140]
5. T Imamura,A Takeshita,T Ashihara,K Yamamoto,S Hoka,M Nakamura.  (1985-01-01)  Digitalis-induced augmentation of cardiopulmonary baroreflex control of forearm vascular resistance..  Circulation,  71  ((1)): (11-16).  [PMID:3964711]
6. L M Vlasenko,E G Nikolaeva,A N Lavreshin.  (1985-04-01)  [Determination of isolanid in cadaveric material]..  Sudebno-meditsinskaia ekspertiza,  28  ((2)): (51-51).  [PMID:4024201]
7. G Lembo,V Rendina,G Iaccarino,N De Luca,B Ricciardelli,M Volpe,B Trimarco.  (1993-12-01)  Digitalis restores the forearm sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy..  Journal of hypertension,  11  ((12)): (1395-1402).  [PMID:8133021]
8. D R Qiao.  (1993-04-01)  [A study on the hemodynamic effect of cedilanid in the treatment of acute myocardial infarction]..  Zhonghua xin xue guan bing za zhi,  21  ((2)): (83-84).  [PMID:8223168]
9. Y Kesim,C Marangoz,M Ayyildiz,N Tasçi,E Agar,H Sahinoglu.  (1994-04-01)  The effects of the purinergic system on digitalis-induced epileptiform activity..  Journal of basic and clinical physiology and pharmacology,  5  ((2)): (167-178).  [PMID:8736047]
10. H Saito,W Kawaguchi,M Iwata,K Maekawa,T Tanimoto,S Okada.  (2000-08-12)  [Lanatoside C Reference Standard (Control 981) of National Institute of Health Sciences]..  Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences,    ((117)(117)): (192-194).  [PMID:10939857]
11. Davy Guillarme,Elia Grata,Gaetan Glauser,Jean-Luc Wolfender,Jean-Luc Veuthey,Serge Rudaz.  (2009-03-03)  Some solutions to obtain very efficient separations in isocratic and gradient modes using small particles size and ultra-high pressure..  Journal of chromatography. A,  1216  ((15)): (3232-3243).  [PMID:19251260]
12. Christian E Badr,Thomas Wurdinger,Jonas Nilsson,Johanna M Niers,Michael Whalen,Alexei Degterev,Bakhos A Tannous.  (2011-07-16)  Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway..  Neuro-oncology,  13  ((11)): (1213-1224).  [PMID:21757445]
13. Yoshihiro Ueda,Kenji Mishiro,Keisuke Yoshida,Takumi Furuta,Takeo Kawabata.  (2012-08-09)  Regioselective diversification of a cardiac glycoside, lanatoside C, by organocatalysis..  The Journal of organic chemistry,  77  ((18)): (7850-7857).  [PMID:22870937]
14. Vasudevan Aparna,Kesavan Dineshkumar,Narasumani Mohanalakshmi,Devadasan Velmurugan,Waheeta Hopper.  (2014-07-16)  Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation..  PloS one,  9  ((7)): (e101840-e101840).  [PMID:25025665]
15. Min-Wu Chao,Tzu-Hsuan Chen,Han-Li Huang,Yu-Wei Chang,Wei-Chun HuangFu,Yu-Ching Lee,Che-Ming Teng,Shiow-Lin Pan.  (2017-04-08)  Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells..  Scientific reports,  7  (46134-46134).  [PMID:28387249]
16. Vahap Murat Kutluay,Toshiaki Makino,Makoto Inoue,Iclal Saracoglu.  (2019-02-09)  New knowledge about old drugs; a cardenolide type glycoside with cytotoxic effect and unusual secondary metabolites from Digitalis grandiflora Miller..  Fitoterapia,  134  (73-80).  [PMID:30735707]
17. Doris L LaRock,Jenna S Sands,Ethan Ettouati,Marine Richard,Paul J Bushway,Eric D Adler,Victor Nizet,Christopher N LaRock.  (2019-07-14)  Inflammasome inhibition blocks cardiac glycoside cell toxicity..  The Journal of biological chemistry,  294  ((34)): (12846-12854).  [PMID:31300552]
18. Baradwaj Gopal Ravi,Mary Grace E Guardian,Rebecca Dickman,Zhen Q Wang.  (2020-02-10)  Profiling and structural analysis of cardenolides in two species of Digitalis using liquid chromatography coupled with high-resolution mass spectrometry..  Journal of chromatography. A,  1618  (460903-460903).  [PMID:32035664]
19. P E Santos,S D Souza,L Freire-Maia,A P Almeida.  (1990-01-01)  Effects of crotoxin on the isolated guinea pig heart..  Toxicon : official journal of the International Society on Toxinology,  28  ((2)): (215-224).  [PMID:2339436]
20. T Sechser,R Petrásek,L Stika,Z Modr,J Elis,J Malý.  (1989-11-01)  Contribution of clinical pharmacology to a rational use of cardiac glycosides in Czechoslovakia..  Polish journal of pharmacology and pharmacy,  41  ((6)): (527-532).  [PMID:2485902]
21. G Weigl.  (1989-01-01)  [Use of digitalis 1981 to 1988 in the Frankfurt (Oder) district]..  Zeitschrift fur arztliche Fortbildung,  83  ((22)): (1115-1116).  [PMID:2629335]
22. R Cristodorescu,G Deutsch,S Drăgan.  (1989-01-01)  Clinical utility of plasma digoxin measurements..  Medecine interne,  27  ((1)): (25-32).  [PMID:2749155]
23. A Marinov.  (1987-01-01)  [Treatment of patients with acute digitalis poisoning by charcoal hemoperfusion]..  Vutreshni bolesti,  26  ((5)): (46-50).  [PMID:3433730]
24. F Orosz,M Nuridsány,J Ovádi.  (1986-07-01)  Isolation and quantitative determination of some cardioactive glycosides from Digitalis lanata by high-performance liquid chromatography..  Analytical biochemistry,  156  ((1)): (171-175).  [PMID:3740407]
25. A Takeshita,T Imamura.  (1986-07-01)  Effects of digitalis on cardiopulmonary baroreflex in man..  Japanese circulation journal,  50  ((7)): (671-674).  [PMID:3773234]
26. A Tracqui,P Kintz,B Ludes,P Mangin.  (1997-04-25)  High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma..  Journal of chromatography. B, Biomedical sciences and applications,  692  ((1)): (101-109).  [PMID:9187389]
27. Iu N Zamotaev,Iu A Kremnev,S E Podshibiakin.  (2005-08-25)  [Cardiac glycosides in complex treatment of patients with heart failure and supraventricular arrhythmias]..  Klinicheskaia meditsina,  83  ((7)): (59-63).  [PMID:16117429]
28. Meliza G Roscani,Silméia G Zanati,Cláudia G Magalhães,Vera T M Borges,Beatriz B Matsubara.  (2009-11-07)  Digitalis-like induced arrhythmia in a patient with rheumatic mitral regurgitation complicated by preeclampsia..  Hypertension in pregnancy,  29  ((2)): (148-152).  [PMID:19891530]
29. Yan Yi Cheung,Karen Caiyun Chen,Huixin Chen,Eng Khuan Seng,Justin Jang Hann Chu.  (2014-09-25)  Antiviral activity of lanatoside C against dengue virus infection..  Antiviral research,  111  (93-99).  [PMID:25251726]
30. Marika H Tesselaar,Thomas Crezee,Imke Schuurmans,Danny Gerrits,James Nagarajah,Otto C Boerman,Ilse van Engen-van Grunsven,Johannes W A Smit,Romana T Netea-Maier,Theo S Plantinga.  (2017-12-16)  Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer..  Journal of nuclear medicine : official publication, Society of Nuclear Medicine,  59  ((5)): (780-786).  [PMID:29242405]
31. Yudong Hu,Kaikai Yu,Gang Wang,Depeng Zhang,Chaoji Shi,Yunhe Ding,Duo Hong,Dan Zhang,Huiqiong He,Lei Sun,Jun-Nian Zheng,Shuyang Sun,Feng Qian.  (2018-02-24)  Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell..  Biochemical pharmacology,  150  (280-292).  [PMID:29475060]
32. Georg Petschenka,Colleen S Fei,Juan J Araya,Susanne Schröder,Barbara N Timmermann,Anurag A Agrawal.  (2018-10-17)  Relative Selectivity of Plant Cardenolides for Na+/K+-ATPases From the Monarch Butterfly and Non-resistant Insects..  Frontiers in plant science,  9  (1424-1424).  [PMID:30323822]
33. Dhanasekhar Reddy,Ranjith Kumavath,Preetam Ghosh,Debmalya Barh.  (2019-12-01)  Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways..  Biomolecules,  9  ((12)):   [PMID:31783627]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.